PAUL M. MEISTER - 08 May 2022 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role: Director
Signature: /s/ Meredith Cook, Attorney-in-Fact
Issuer symbol: AMRX
Transactions as of: 08 May 2022
Net transactions value: $0
Form type: 4
Filing time: 10 May 2022, 18:46:56 UTC
Previous filing: 28 Apr 2022
Next filing: 06 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMRX	Class A Common Stock	Options Exercise		+52,677	+12%		508,479	08 May 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMRX	Restricted Stock Units	Options Exercise	$0	-52,677	-100%	$0.000000^*	0	08 May 2022	Class A Common Stock	52,677		Direct	F1, F2
transaction	AMRX	Restricted Stock Units	Award	$0	+112,179		$0.000000	112,179	09 May 2022	Class A Common Stock	112,179		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2	On May 5, 2021 the reporting person was granted 52,677 restricted stock units vesting on May 8, 2022.
F3	Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.